Paul Chapman
Memorial Sloan Kettering Cancer Center
3
3
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jeffrey Weber
University of Southern California
Shared therapeutic areas:
Worked with same sponsors:
Muralidhar Beeram
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
Shared therapeutic areas:
Worked with same sponsors:
David Solit
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Kevin Kim
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Thomas Gajewski
University of Chicago Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Svetomir Markovic
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Joseph Skitzki
Roswell Park Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Wenyin Shi, MD, PhD
Thomas Jefferson University
Shared therapeutic areas:
Takami Sato, MD
Thomas Jefferson University
Shared therapeutic areas:
Mitchell Kamrava
Jonsson Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Tanespimycin in Treating Patients With Stage III-IV Melanoma
MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
All 3 trials loaded